Philip Morris is scheduled to announce its second-quarter results later this month, with analysts anticipating a double-digit earnings growth.

Philip Morris International Inc. rated Hold with $170 target: strong smoke-free growth & margins vs. peers. Click for PM ...

Philip Morris shines with smoke-free success, but premium valuation and lower yield limit upside. Click here to read an ...

Some pediatric doctors in the metro Atlanta area say they’re alarmed by the soaring use of nicotine pouches by teens. The ...

ZYN nicotine pouches have rapidly emerged as the hottest name in smokeless alternatives: dominating headlines, flying off ...

For investors looking at the tobacco sector in 2025, the choice often comes down to two giants — Altria Group, Inc. MO and ...

Philip Morris International has pulled off a jaw-dropping transformation that has investors grinning like Cheshire cats. The ...

And over the past several years, they’ve skyrocketed in popularity.

Philip Morris is leaning hard into smoke-free products, and investors are lighting up—not cigarettes, but their portfolios.

Nicotine pouch maker a step closer to doing so after FDA moves forward modified risk tobacco product applications ...

Philip Morris delivered results ahead of Wall Street’s expectations in Q1, driven primarily by strong momentum in its ...